Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Stable and easily available sulfide surrogates allow a stereoselective activation of alcohols

Jérémy Merad ab, Ján Matyašovský a, Tobias Stopka a, Bogdan R. Brutiu§ a, Alexandre Pinto§ a, Martina Drescher a and Nuno Maulide *a
aDepartment of Organic Chemistry, University of Vienna, Währinger Straße 38, 1090 Vienna, Austria. E-mail: nuno.maulide@univie.ac.at; Web: http://maulide.univie.ac.at
bUniv. Lyon, Université Claude Bernard Lyon 1, CNRS CPE Lyon, INSA Lyon, ICBMS, UMR 5246 Bât. Lederer, 1 rue Victor Grignard, 69622 Villeurbanne, France

Received 20th March 2021 , Accepted 28th April 2021

First published on 6th May 2021


Abstract

Isothiouronium salts are easily accessible and stable compounds. Herein, we report their use as versatile deoxasulfenylating agents enabling a stereoselective, thiol-free protocol for synthesis of thioethers from alcohols. The method is simple, scalable and tolerates a broad range of functional groups otherwise incompatible with other methods. Late-stage modification of several pharmaceuticals provides access to multiple analogues of biologically relevant molecules. Performed experiments give insight into the reaction mechanism.


Introduction

Sulfur is the 5th most abundant element (after C, H, O and N) in pharmaceuticals and agrochemicals. Indeed, more than 20% of recently approved drugs contain at least one sulfur atom.1 This widespread occurrence is likely due to this element's oxidation-state versatility, from thioethers and sulfonium salts to sulfoxides, sulfones and their derivatives.

In addition to being constitutive of multiple bioactive molecules,1 thioethers (or sulfides) readily participate in substitution and cross-coupling reactions.2 Thus, synthetic approaches allowing the incorporation of divalent sulfur have been vigorously investigated during past decades.3 A traditional SN2-type approach is still the method of choice for most synthetic applications. In fact, catalytic nucleophilic substitutions have recently emerged as alternatives to traditional approaches,4 relying on in situ activation of (secondary) alcohols, ultimately leading to amines, esters, azides or halides with high selectivities.5 Classical strategies, however, require prior functional group interconversion (FGI) when alcohols and thiols are considered as the reaction substrates, effectively employing two linear steps to achieve this transformation (Scheme 1A). Reactions of chiral alcohols in such a way generally provide the desired thioethers with clean inversion of configuration (unless SN1-type processes operate, such as with benzylic, allylic or tertiary alcohols under acid catalysis).6 Alternatively, the stepwise conversion of alcohols into thioethers via halides proceeds with retention of configuration due to twofold inversion. Thio-Mitsunobu reaction efficiently converts alcohols into thioethers, while requiring a combination of two stoichiometric activating agents (Scheme 1A). Again the reaction generally proceeds with stereochemical inversion of configuration for secondary alcohols.7 However, aliphatic thiols are mostly considered unsuitable for the Mitsunobu reaction, as the thiol group itself is not acidic enough for the reaction to take place.7b Additionally, there are noteworthy functional group tolerance issues in Mitsunobu-type protocols (e.g. azides or peroxides are incompatible with the phosphine reactants typical of Mitsunobu procedures). Finally, both of these methods employ practically unsuitable thiols as the nucleophilic components. Indeed, more than being notoriously malodorant compounds and susceptible to oxidation, very few thiols are commercially available, severely limiting the diversity of readily accessible thioether derivatives.


image file: d1sc01602d-s1.tif
Scheme 1 Synthetic strategies to access thioethers from alcohols.

Isothiouronium salts are odorless, stable, easily accessible compounds, which represent potentially interesting activators for the hydroxyl group. Indeed, Kajigaeshi published a general one-pot two-step convergent strategy for preparation of thioethers from primary alcohols utilizing isothiouronium salts (Scheme 1B).8 This work showcases 12 examples with moderate yields, but establishes precedence for using thiouronium salts. Proline-derived cyclic iminium salts were used in a similar work in an attempt to kinetically resolve secondary benzylic alcohols with mediocre results (Scheme 1C).9 Related iminium salts were used for preparation of alkyl(tetrazolyl)sulfides using an exogenous aryl thiol or for deoxygenative iodination of alcohols, with notorious erosion of stereochemical purity of enantiopure starting material.10 Analogous reagents have also found limited applications in the syntheses of 2-pyridinethioesters,11a Barton's esters,11bN-thioalkenyl and N-(o-thio)aryl-benzimidazol-2-ones.11c Thioimidazolinium salts have been used extensively for the preparation of sulfides or as cyanation agents.12 Hopkinson recently demonstrated that benzothiazolium reagents can be used in trifluoromethyl(alkyl) sulfide synthesis or fluorinated thioester synthesis.13 However, to the best of our knowledge, a successful chiral thioether synthesis using isothiouronium salts involving a configuration inversion of enantiopure secondary alcohols has not been reported. Additionally, we believe that the straightforward reactivity of uronium salts could prove advantageous in a range of synthetic contexts ranging from late-stage modification to enabling preparation of thioethers carrying sensitive functional groups. Herein, we report our findings in all of the above-mentioned endeavours (Scheme 1D).

Results and discussion

Taking Kajigaeshi's work8 into consideration, it is reasonable to assume that the thioetherification of most primary alcohols involves an SN2-type mechanism. However, it remained unclear how such a reaction manifold would hold for more hindered substrates. In particular, the possibility of SN1/SN2 mechanistic competition and its impact on stereocontrol appeared to be potential pitfalls, especially for secondary benzylic/allylic alcohols. After a survey of reaction conditions,14 deoxasulfenylation using the thiouronium bromide 1a was performed on enantiopure (>99% ee) (R)-1-phenylethan-1-ol (Scheme 2) in order to discriminate between these two possible mechanisms. Thioether 2a was obtained in 71% yield and a moderate 73% ee. While it was tempting to interpret this result as a consequence of simultaneous operation of SN2 and SN1-type pathways, we also wondered if the counterion X of the isothiouronium reactant 1a might play a non-innocent role.9 Indeed, bromide is a competent nucleophile while also serving as a good leaving group, an ability best expressed in Finkelstein and related reactions.15 Therefore, exchanging the bromide counteranion of isothiouronium 1a for the less nucleophilic hexafluoroantimonate using AgSbF6 in water gave the salt 1aa in 84% yield. Repeating the deoxysulfenylation reaction with 1aa resulted in excellent inversion of configuration (96% ee), while the yield of the reaction remained unchanged. Additionally, the stereochemical outcome of the reaction was the same utilizing either tetrafluoroborate (1ab, 96% ee) or hexafluorophosphate thiouronium salts (1ac, 97% ee), while the overall reaction yields dropped slightly.14 Similarly excellent results were observed when related isothiouronium antimonate 1bb was employed (product 2b, 73% yield, 97% ee). Other chiral secondary alcohols were then investigated. A slight drop in ee was observed for naphtyl-bearing substrate 2c (82% ee), while the presence of electron-withdrawing groups led to a product with >99% ee (2d). Excellent results were also obtained with propargylic substrates (2e and 2f, >97% ee). A successful diastereoselective thioetherification of an allylic substrate 2g provided the desired thioether as a single diastereomer when isothiouronium 1bb was used (compared to increased amounts of a second diastereomer, when salt 1b was used). Finally, to unambiguously verify SN2-type inversion of configuration, thioether 2h was prepared in 67% yield and >98% ee. The optical rotation was in good agreement with the value reported in the literature ([α]20D = −57.4 (c = 1, CHCl3); lit. [α]20D = −54.7 (c = 1, CHCl3)).16,17
image file: d1sc01602d-s2.tif
Scheme 2 Thioetherification of optically active secondary alcohols: impact of the counteranion. aReactions were performed at rt for 2 h with alcohol (0.30 mmol, 1.0 equiv.), isothiouronium salt (0.30 mmol, 1.0 equiv.) and BTMG (0.33 mmol, 1.1 equiv.) in CHCl3 (0.14 M concentration). bReaction conditions: AgSbF6, H2O (0.35 M), rt, 30 min, 84% yield. Yields refer to isolated products. BTMG = 2-tert-butyl-1,1,3,3-tetramethylguanidine.

The synthetic potential of isothiouronium salts in deoxasulfenylation reactions was then investigated in late-stage derivatisation (Scheme 3). Indeed, several clinically used drugs carry free hydroxyl groups and we were eager to probe these salts in such challenging, functional-group-rich contexts.


image file: d1sc01602d-s3.tif
Scheme 3 Late-stage modification of various drugs. aReactions were performed at rt for 2 h with the corresponding drug (0.30 mmol, 1.0 equiv.), isothiouronium salt (0.30 mmol, 1.0 equiv.) and BTMG (0.33 mmol, 1.1 equiv.) in CHCl3 (0.14 M concentration). Yields refer to isolated products. bThio-Mitsunobu conditions: dihydroartemisinin (0.2 mmol, 1.0 equiv.), thiol (0.2 mmol, 1.0 equiv.), PPh3 (0.3 mmol, 1.5 equiv.), diethyl azodicarboxylate (0.3 mmol, 1.5 equiv.) in THF (at 0.1 M concentration). Yield 0%.

As shown, several nitrogen-containing bioactive compounds such as metronidazole (antibiotic), quetiapine (antipsychotic), atropine (antispasmodic) and trityl-losartan (antihypertensive) were smoothly converted to their corresponding thioethers (3a–e). The modification of prednisone (3f) and corticosterone (3g) proved to be perfectly chemoselective despite the presence of reactive Michael acceptors (enones) and multiple hydroxyl groups: the result with corticosterone (3g) additionally suggests useful chemoselectivity between primary and secondary alcohols. The derivatization of dihydroartemisinin (3h) is particularly relevant, since standard thio-Mitsunobu conditions led only to decomposition of this redox-sensitive substrate possessing cyclic peroxide. Notably, it has been shown that C-10 thioethers derived from artemisinine display significant anticancer activity.18

Finally, we wanted to extend the portfolio of substrates to other primary and secondary alcohols (Scheme 4).8 Thioetherification of diversely substituted alcohols with salt 1b efficiently delivered products 4a and 4b. In order to probe robustness and reproducibility, the synthesis of thioether 4a was also performed with technical solvents, under open-flask conditions as well as on a gram scale without any erosion of the yield. β-Citronellol led to the desired thioether 4c in 75% yield. Deoxasulfenylation of several allylic (4d–f), propargylic (4g) and α-(heteroaryl) alcohols (4h–j) occurred smoothly with perfect regioselectivity (no products resulting from SN2′-type reaction were observed). Pleasingly, the transformation remains efficient in the presence of phenols (4k) and azides (4l). Such substrates are indeed challenging in classical Mitsunobu reactions, due to the nucleophilicity of phenoxide anion and the fast reaction between azides and phosphines. Preparation of 4l was nevertheless attempted under thio-Mitsunobu conditions, showing no product being formed. Moreover, a silylether is also tolerated (4m). The methodology was successfully extended to secondary alcohols to afford the corresponding thioethers 4n and 4o in satisfying yields. Aliphatic secondary alcohols did not react as efficiently, providing the desired sulfide in 33% yield using slightly modified reaction conditions (4p). We next turned our attention to the structure of the transferable S-containing residues (Scheme 4). This switch led us to prepare thioethers 4a, 4b and 4d by forging the opposite C–S bond. This demonstrates the versatility of this approach, enabling access to the same product by either of two disconnections depending on the accessibility of the starting materials. Thioethers incorporating methyl (4q), isopropyl (4r), and propargyl (4s) groups were prepared in good yields. Also, several allylic thiols were transferred to access polyunsaturated compounds 4t–v. However, no conversion was observed with tertiary alcohols (5a), likely due to high steric hindrance. Additionally, the reaction did not result in desired products when either hydroxyalkyl halide (5b) or crotonate derived alcohol (5c) were employed as substrates.19


image file: d1sc01602d-s4.tif
Scheme 4 Thioetherification scope. aReactions were performed at rt for 2 h with alcohol (0.30 mmol, 1.0 equiv.), isothiouronium salt (0.30 mmol, 1.0 equiv.) and BTMG (0.33 mmol, 1.1 equiv.) in CHCl3 (0.14 M concentration). Yields refer to isolated products. bOpen-flask conditions. cGram scale. dBTMG = 2.2 equiv. eThio-Mitsunobu conditions: azidoalcohol (0.2 mmol, 1.0 equiv.), thiol (0.2 mmol, 1.0 equiv.), PPh3 (0.3 mmol, 1.5 equiv.), diethyl azodicarboxylate (0.3 mmol, 1.5 equiv.) in THF (at 0.1 M concentration). Yield 0%. fReaction time 14 h (at 1 M concentration).

The result of the reaction of alcohol 5b, namely the formation of thioether 6 and dibromide 7 (cf.Scheme 5) resulting from two consecutive substitutions, prompted us to reevaluate the reaction mechanism. The same result was obtained even when SbF6 isothiouronium salt 1bb was used in the reaction, suggesting that the thiol/thiolate liberated during the reaction can react either at the carbon carrying the bromide or the isouronium moiety (Scheme 5A).20 Based on these findings, we propose a modified reaction mechanism. Addition of alcohol onto 1 provides hemithioacetal I, in equilibrium with ion pair II (Nu = SR). At this stage, any halide anion present can act as a competing nucleophile, causing formation of intermediate III. This effect is eliminated when the SbF6 salt is used. Finally, irreversible nucleophilic displacement of the isouronium in II (leading to urea derivative 8) or the halide in III provides the desired thioethers (Scheme 5B). The double substitution products of Scheme 5A appear to be the consequence of bromide displacement by thiolate competing with SN2-collapse of ion pair II.


image file: d1sc01602d-s5.tif
Scheme 5 Mechanistic insight into thioetherification of alcohols using isothiouronium salts.

Conclusions

In summary, we report that easily preparable isothiouronium salts serve as convenient deoxasulfenylating reagents for alcohols. Stereoinversion of chiral secondary alcohols was shown to be counteranion dependent, leading to clean inversion of configuration. Late-stage modification of several biologically relevant substances is enabled by this procedure. This method offers straightforward access to thioethers and constitutes a valuable alternative to the established methods. This is particularly visible on substrates otherwise incompatible with thio-Mitsunobu reaction protocols. Finally, our findings provided mechanistic insight into the reaction. We believe that these reactions of isothiouronium salts might be of interest as rapid and mild methods for conjugation.

Author contributions

The work was conceptualized by J. Merad and N. M. The first draft of the manuscript was written by J. Merad and J. Matyašovský, all of the authors contributed to the final version of the manuscript. The experiments were performed by J. Merad, J. Matyašovský, T. S., B. R. B., A. P. and M. D. N. M. was involved in securing funding, manuscript editing and finalizing and overall supervision of the project.

Conflicts of interest

There are no conflicts to declare.

Acknowledgements

Generous support of this research by the EU (VINCAT CoG 682002 to N. M.), the Austrian Science Fund (P32607) and Covestro AG is acknowledged. We are grateful to the University of Vienna for its continued and generous support of our research programs.

Notes and references

  1. (a) M. Feng, B. Tang, S. H. Liang and X. Jiang, Curr. Top. Med. Chem., 2016, 16(11), 1200–1216 CrossRef CAS PubMed ; (b) K. A. Scott and J. T. Njardarson, Top. Curr. Chem., 2018, 376, 5 CrossRef PubMed ; (c) E. A. Ilardi, E. Vitaku and J. T. Njardarson, J. Med. Chem., 2014, 57, 2832–2842 CrossRef CAS PubMed ; (d) B. R. Smith, C. M. Eastman and J. T. Njardarson, J. Med. Chem., 2014, 57, 9764–9773 CrossRef CAS PubMed ; (e) P. Das, M. D. Delost, M. H. Qureshi, D. T. Smith and J. T. Njardarson, J. Med. Chem., 2019, 62, 4265–4311 CrossRef CAS PubMed .
  2. (a) C. M. Rayner, Contemp. Org. Synth., 1995, 2, 409–440 RSC ; (b) M. Tobisu, Y. Masuya, K. Babaa and N. Chatani, Chem. Sci., 2016, 7, 2587–2591 RSC ; (c) J. F. Hooper, A. B. Chaplin, C. González-Rodríguez, A. L. Thompson, A. S. Weller and M. C. Willis, J. Am. Chem. Soc., 2012, 134, 2906–2909 CrossRef CAS PubMed ; (d) D. Zhu and L. Shi, Chem. Commun., 2018, 54, 9313–9316 RSC .
  3. (a) D. J. Procter, J. Chem. Soc., Perkin Trans. 1, 2001, 335–354 RSC ; (b) J. Clayden and P. MacLellan, Beilstein J. Org. Chem., 2011, 7, 582–595 CrossRef CAS PubMed ; (c) R. W. Dugger, J. A. Ragan and D. H. Brown Ripin, Org. Process Res. Dev., 2005, 9, 253–258 CrossRef CAS ; (d) J. S. Carey, D. Laffan, C. Thomson and M. T. Williams, Org. Biomol. Chem., 2006, 4, 2337–2347 RSC .
  4. (a) J. An, R. M. Denton, T. H. Lambert and E. D. Nacsa, Org. Biomol. Chem., 2014, 12, 2993–3003 RSC ; (b) P. H. Huy, Eur. J. Org. Chem., 2020, 10–27 CrossRef CAS .
  5. (a) P. H. Huy, S. Motsch and S. M. Kappler, Angew. Chem., Int. Ed., 2016, 55, 10145–10149 CrossRef CAS PubMed ; (b) R. H. Beddoe, K. G. Andrews, V. Magné, J. D. Cuthbertson, J. Saska, A. L. Shannon-Little, S. E. Shanahan, H. F. Sneddon and R. M. Denton, Science, 2019, 365, 910–914 CrossRef CAS PubMed .
  6. (a) Acid Catalysis in Modern Organic Synthesis, ed. H. Yamamoto and K. Ishihara, Wiley-VCH, Weinheim, 2008 Search PubMed ; (b) E. Emer, R. Sinisi, M. G. Capdevila, D. Petruzziello, F. De Vincentiis and P. G. Cozzi, Eur. J. Org. Chem., 2011, 647–666 CrossRef CAS .
  7. (a) O. Mitsunobu, Synthesis, 1981, 1–28 CrossRef CAS ; (b) K. C. Kumara Swamy, N. N. Bhuvan Kumar, E. Balaraman and K. V. P. Pavan Kumar, Chem. Rev., 2009, 109, 2551–2651 CrossRef PubMed ; (c) K. A. M. Walker, Tetrahedron Lett., 1977, 18, 4475–4478 CrossRef ; (d) H. Kotsuki, K. Matsumoto and H. Nishizawa, Tetrahedron Lett., 1991, 32, 4155–4158 CrossRef CAS .
  8. S. Fujisaki, I. Fujiwara, Y. Norisue and S. Kajigaeshi, Bull. Chem. Soc. Jpn., 1985, 58, 2429–2430 CrossRef CAS .
  9. R. A. Aitken, K. Ali and S. T. E. Mesher, Tetrahedron Lett., 1997, 38, 4179–4182 CrossRef CAS .
  10. (a) A. R. Ellwood and M. J. Porter, Org. Biomol. Chem., 2011, 9, 379–381 RSC ; (b) A. R. Ellwood and M. J. Porter, J. Org. Chem., 2009, 74, 7982–7985 CrossRef CAS PubMed .
  11. (a) N. Scardovi, P. G. Garner and J. D. Protasiewicz, Org. Lett., 2003, 5, 1633–1635 CrossRef CAS PubMed ; (b) P. Garner, J. T. Anderson, S. Dey, W. J. Youngs and K. Galat, J. Org. Chem., 1998, 63, 5732–5733 CrossRef CAS PubMed ; (c) F. Andreoli, R. Kaid-Slimane, F. Coppola, D. Farran, C. Rousell and N. Vanthuyne, J. Org. Chem., 2015, 80, 3233–3241 CrossRef CAS PubMed .
  12. (a) M. Zhao, A. G. Barrado, K. Sprenger, C. Golz, R. A. Mata and M. Alcarazo, Org. Lett., 2020, 22, 4932–4937 CrossRef CAS PubMed ; (b) S. I. Kozhushkov and M. Alcarazo, Eur. J. Inorg. Chem., 2020, 2486–2500 CrossRef CAS PubMed ; (c) M. J. Böhm, C. Golz, I. Reter and M. Alcarazo, Chem.–Eur. J., 2018, 24, 15026–15035 CrossRef PubMed ; (d) J. Peña, G. Talavera, B. Waldecker and M. Alcarazo, Chem.–Eur. J., 2017, 23, 75–78 CrossRef PubMed .
  13. (a) S. Dix, M. Jakob and M. N. Hopkinson, Chem.–Eur. J., 2019, 25, 7635–7639 CrossRef CAS PubMed ; (b) M. Tironi, L. M. Maas, A. Garg, S. Dix, J. P. Götze and M. N. Hopkinson, Org. Lett., 2020, 22, 8925–8930 CrossRef CAS PubMed .
  14. For screening of bases, solvents and counteranions see ESI..
  15. (a) H. Finkelstein, Ber. Dtsch. Chem. Ges., 1910, 43, 1528–1532 CrossRef CAS ; (b) S. S. Shinde, B. S. Lee and D. Y. Chi, Org. Lett., 2008, 10, 733–735 CrossRef CAS PubMed ; (c) A. Taher, K. C. Lee, H. J. Han and D. W. Kim, Org. Lett., 2017, 19, 3342–3345 CrossRef CAS PubMed .
  16. S. S. Khokhar and T. Wirth, Eur. J. Org. Chem., 2004, 4567–4581 CrossRef CAS .
  17. Enantioenriched alcohols located α- or β- to a carbonyl group led to racemic products. See ESI for details (2i–2k).
  18. R. Gour, F. Ahmad, S. Prajapati, S. Giri, S. Karna, K. Kartha and Y. Pokharel, Eur. J. Med. Chem., 2019, 178, 552–570 CrossRef CAS PubMed .
  19. Alcohol 5c afforded products of both 1,4-addition and substitution. See ESI for details (4v).
  20. See ESI for details.

Footnotes

Electronic supplementary information (ESI) available. See DOI: 10.1039/d1sc01602d
These authors contributed equally to this manuscript.
§ These authors contributed equally to this manuscript.

This journal is © The Royal Society of Chemistry 2021